Monsanto may lose European license for products with glyphosate
Mar 09, 2016
A big battle is being fought in Europe over Monsanto’s Roundup, which contains the chemical glysophate. It has been shown to be a carcinogen, but Monsanto’s political power is being opposed by scientists from around Europe. Many nations have already banned Roundup, but Europe’s decision will be a major key to Monsanto’s future.
A battle of corporate profit vs people’s needs has been fought out at the European Union over the past two days as heated negotiations took place about the re-licencing of a chemical that probably causes cancer in humans. It just so happens that this very same chemical makes millions in profit for the giant chemical and seed company Monsanto.
For now, neither side has emerged victorious as the decision about whether to relicense glyphosate, which was due to be voted on today, has been postponed until May….
Concerns about the safety of glyphosate were corroborated by the World Health Organisation’s 2015 breakthrough study finding glyphosate to be “probably carcinogenic to humans”.
This serious threat to public health was behind the decision of a number of member states including France, Sweden and Italy to announce in recent days that they would be voting against the relicensing of glyphosate. It also drove 1.5million people to sign Avaaz’s petition urging the EU not to relicense it.
Dr. Stephen Jones